• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Synta Pharmaceuticals Corp

+ Add to Watchlist

SNTA:US

2.6300 USD 0.0200 0.77%

As of 17:10:00 ET on 12/24/2014.

Company Profile for Synta Pharmaceuticals Corp (SNTA)

Synta Pharmaceuticals Corp. is a biopharmaceutical company developing small-molecule drugs for inflammatory diseases, cancer, and diabetes. The Company has drug candidates in human clinical trials and additional programs in preclinical studies.

Contact Information

Synta Pharmaceuticals Corp

45 Hartwell Avenue
Lexington, MA 02421
United States
Phone: 1-781-274-8200
Fax: 1-781-274-8228

Key Executives for Synta Pharmaceuticals Corp (SNTA)

Anne C WhitakerPresident/CEOChen SchorExec VP/COO
Marc R SchneebaumSenior VP/CFOVojo VukovicSenior VP/Chief Medical Ofcr
Arthur McMahon "Art"Senior VP:People OperationsWendy E RiederVP:Intellectual Property/Secy
Mindy S KohlAssociate Dir:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil